Major histocompatibility complex controls the trajectory but not host-specific adaptation during virulence evolution of the pathogenic fungus Cryptococcus neoformans

Proceedings of the Royal Society B: Biological Sciences

Volumn 271, Issue 1548, 2004, Pages 1557-1564

  McClelland, Erin E ^a,c   Adler, Frederick R ^a   Granger, Donald L ^b   Potts, Wayne K ^a  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Cryptococcus neoformans; Emerging pathogens; Major histocompatibility complex; Pathogen adaptation

Indexed keywords

EVOLUTION; FUNGUS; PATHOGEN; VIRULENCE;

ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; CELL LINE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; EVOLUTIONARY ADAPTATION; FUNGAL DETECTION; FUNGAL VIRULENCE; GENE REPLICATION; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; MORTALITY; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; TIME; YEAST;

ANIMALIA; FILOBASIDIELLA NEOFORMANS; FUNGI;

EID: 3242879786     PISSN: 09628452     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rspb.2004.2736     Document Type: Article

References (54)

1. Allen, T. M. (and 18 others) 2000 Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Nature 407, 386-390.
2. Apanius, V., Penn, D., Slev, P., Ruff, L. R. & Potts, W. K. 1997 The nature of selection on the major histocompatibility complex. Crit. Rev. Immunol. 17, 179-224.
3. + T-cell repertoire: implications for autoimmune disease. Cytokines Cell Mol. Ther. 3, 115-125.
4. Beltman, J. B., Borghans, J. A. M. & De Boer, R. J. 2001 Major histocompatibility complex: polymorphism from coevolution. In Adaptive dynamics of infectious diseases: in pursuit of virulence management (ed. U. Dieckmann, J. A. J. Metz, M. W. Sabelis & K. Sigmund), pp. 210-221. Cambridge University Press.
5. Bertoletti, A., Sette, A., Chisari, F. V., Penna, A., Levrero, M., De Carli, M., Fiaccadori, F. & Ferrari, C. 1994 Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 369, 407-410.
6. Blake, J. A., Richardson, J. E., Bult, C. J., Kadin, J. A. & Eppig, J. T. 2002 The Mouse Genome Database (MGD): the model organism database for the laboratory mouse. Nucleic Acids Res. 30, 113-115.
7. Bodmer, W. F. 1972 Evolutionary significance of the HL-A system. Nature 237, 139-145.
8. Borghans, J. A., Beltman, J. B. & De Boer, R. J. 2004 MHC polymorphism under host-pathogen coevolution. Immunogenetics 55, 732-739.
9. Brown, E. G., Liu, H., Kit, L. C., Baird, S. & Nesrallah, M. 2001 Pattern of mutation in the genome of influenza A virus on adaptation to increased virulence in the mouse lung: identification of functional themes. Proc. Natl Acad. Sci. USA 98, 6883-6888.
10. Campisi, E., Mancianti, F., Pini, G., Faggi, E. & Gargani, G. 2003 Investigation in Central Italy of the possible association between Cryptococcus neoformans var. Gattii and Eucalyptus camaldulensis. Eur. J. Epidemiol. 18, 357-362.
11. Carrington, M. & Bontrop, R. E. 2002 Effects of MHC class I on HIV/SIV disease in primates. AIDS 16(Suppl. 4), S105-S114.
12. Carrington, M., Nelson, G. W., Martin, M. P., Kissner, T., Vlahov, D., Goedert, J. J., Kaslow, R., Buchbinder, S., Hoots, K. & O'Brien, S. J. 1999 HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 283, 1748-1752.
13. 2 segregants. J. Immunol. Meth. 257, 137-143.
14. Crill, W. D., Wichman, H. A. & Bull, J. J. 2000 Evolutionary reversals during viral adaptation to alternating hosts. Genetics 154, 27-37.
15. de Campos Lima, P. O., Levitsky, V., Brooks, J., Lee, S. P., Hu, L. F., Rickinson, A. B. & Masucci, M. G. 1994 T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues. J. Exp. Med. 179, 1297-1305.
16. Dobson, C. & Owen, M. E. 1977 Influence of serial passage on the infectivity and immunogenicity of Nematospiroides dubius in mice. Int. J. Parasitol. 1, 463-466.
17. Dybdahl, M. F. & Lively, C. M. 1998 Host-parasite coevolution: evidence for rare advantage and time-lagged selection in a natural population. Evolution 52, 1057-1066.
18. Ebert, D. 1998 Experimental evolution of parasites. Science 282, 1432-1435.
19. Ebert, D. & Bull, J. J. 2003 Challenging the trade-off model for the evolution of virulence: is virulence management feasible? Trends Microbiol. 11, 15-20.
20. Ebert, D. & Hamilton, W. D. 1996 Sex against virulence: the coevolution of parasitic diseases. Trends Ecol. Evol. 11, 79-82.
21. Evans, D. T. (and 16 others) 1999 Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef. Nature Med. 5, 1270-1276.
22. Fischer, H. G., Dorfler, R., Schade, B. & Hadding, U. 1999 Differential CD86/B7-2 expression and cytokine secretion induced by Toxoplasma gondii in macrophages from resistant or susceptible BALB H-2 congenic mice. Int. Immunol. 11, 341-349.
23. Gerlai, R. 1996 Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype? Trends Neurosci. 19, 177-181.
24. Glazier, A. M., Nadeau, J. H. & Aitman, T. J. 2002 Finding genes that underlie complex traits. Science 298, 2345-2349.
25. Haldane, J. B. S. 1949 Disease and evolution. La Ricerca Scientifica 19, 68-75.
26. Hamilton, W. D. 1982 Pathogens as causes of genetic diversity in their host populations. In Population biology of infectious diseases (ed. R. M. Anderson & R. M. May), pp. 269-296. Berlin: Springer.
27. Hildesheim, A. & Wang, S. S. 2002 Host and viral genetics and risk of cervical cancer: a review. Virus Res. 89, 229-240.
28. Hosono, S., Tai, P. C., Wang, W., Ambrose, M., Hwang, D. G., Yuan, T. T., Peng, B. H., Yang, C. S., Lee, C. S. & Shih, C. 1995 Core antigen mutations of human hepatitis B virus in hepatomas accumulate in MHC class II-restricted T cell epitopes. Virology 212, 151-162.
29. Kaltz, O. & Bell, G. 2002 The ecology and genetics of fitness in Chlamydomonas. XII. Repeated sexual episodes increase rates of adaptation to novel environments. Evol. Int. J. Organic Evol. 56, 1743-1753.
30. McClelland, E. E., Penn, D. J. & Potts, W. K. 2003a Major histocompatibility complex heterozygote superiority during coinfection. Infect. Immun. 71, 2079-2086.
31. McClelland, E. E., Granger, D. L. & Potts, W. K. 2003b MHC-dependent susceptibility to Cryptococcus neoformans in mice. Infect. Immun. 71, 4815-4817.
32. Mackinnon, M. J., Gaffney, D. J. & Read, A. F. 2002 Virulence in rodent malaria: host genotype by parasite genotype interactions. Infect. Genet. Evol. 1, 287-296.
33. McMichael, A. J. & Phillips, R. E. 1997 Escape of human immunodeficiency virus from immune control. A. Rev. Immunol. 15, 271-296.
34. Meadows, R. L., MacWilliams, P. S., Dzata, G. & Meinen, J. 1993 Chylothorax associated with cryptococcal mediastinal granuloma in a cat. Vet. Clin. Pathol. 22, 109-116.
35. Messenger, S. L., Molineux, I. J. & Bull, J. J. 1999 Virulence evolution in a virus obeys a trade-off. Proc. R. Soc. Lond. B 266, 397-404. (DOI 10.1098/rspb.1999.0651.)
36. Murray, J. S., Ferrandis-Edwards, D., Wolfe, C. J. & Schountz, T. 1994 Major histocompatibility complex regulation of T helper functions mapped to a peptide C terminus that controls ligand density. Eur. J. Immunol. 24, 2337-2344.
37. O'Toole, T. E., Sato, A. F. & Rozanski, E. A. 2003 Cryptococcosis of the central nervous system in a dog. J. Am. Vet. Med. Assoc. 222, 1722-1725.
38. Penn, D. & Potts, W. 1999 The evolution of mating preferences and major histocompatibility genes. Am. Nat. 153, 145-164.
39. Perfect, J. R., Lang, S. D. & Durack, D. T. 1980 Chronic cryptococcal meningitis: a new experimental model in rabbits. Am. J. Pathol. 101, 177-194.
40. Pewe, L, Wu, G. F., Barnett, E. M., Castro, R. F. & Perlman, S. 1996 Cytotoxic T cell-resistant variants are selected in a virus-induced demyelinating disease. Immunity 5, 253-262.
41. Pircher, H., Moskophidis, D., Rohrer, U., Bürki, K., Hengartner, H. & Zinkernagel, R. M. 1990 Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature 346, 629-632.
42. Potts, W. K. & Slev, P. R. 1995 Pathogen-based models favoring MHC genetic diversity. Immunol. Rev. 143, 181-197.
43. Preston, B. D., Poiesz, B. J. & Loeb, L. A. 1988 Fidelity of HIV-1 reverse transcriptase. Science 242, 1168-1171.
44. Regoes, R. R., Nowak, M. A. & Bonhoeffer, S. 2000 Evolution of virulence in a heterogeneous host population. Evolution 54, 64-71.
45. Roberts, J. D., Bebenek, K. & Kunkel, T. A. 1988 The accuracy of reverse transcriptase from HIV-1. Science 242, 1171-1173.
46. Saha, B. K. & Cullen, S. E. 1986 Molecular mapping of murine I region recombinants: crossing over in the E beta gene. J. Immunol. 136, 1112-1119.
47. Takahata, N. & Nei, M. 1990 Allelic genealogy under over-dominant and frequency-dependent selection and polymorphism of major histocompatibility complex loci. Genetics 124, 967-978.
48. Thursz, M. R., Thomas, H. C., Greenwood, B. M. & Hill, A. V. 1997 Heterozygote advantage for HLA class-II type in hepatitis B virus infection. Nature Genet. 17, 11-12.
49. Wolfer, D. P. & Lipp, H. P. 2000 Dissecting the behaviour of transgenic mice: is it the mutation, the genetic background, or the environment? Exp. Physiol. 85, 627-634.
50. Woolhouse, M. E. 2002 Population biology of emerging and re-emerging pathogens. Trends Microbiol. 10(Suppl. 10), S3-S7.
51. Woolhouse, M. E., Webster, J. P., Domingo, E., Charles-worth, B. & Levin, B. R. 2002 Biological and biomedical implications of the co-evolution of pathogens and their hosts. Nature Genet. 32, 569-577.
52. (+) T cells controls the direction of the T(h) cell response. Int. Immunol. 14, 1-11.
53. Yewdell, J. W. & Bennink, J. R. 1999 Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. A. Rev. Immunol. 17, 51-88.
54. Yoshida, A., Koide, Y., Uchijima, M. & Yoshida, T. O. 1995 Dissection of strain difference in acquired protective immunity against Mycobacterium bovis Calmette-Guerin bacillus (BCG). Macrophages regulate the susceptibility through cytokine network and the induction of nitric oxide synthase. J. Immunol. 155, 2057-2066.